CA
CELG

Cullinan Associates’s Celgene Corp CELG Stock Holding History

Cullinan Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,340
Closed -$1.23M – 187
2019
Q3 		$1.23M Hold
12,340
– – 0.09% 120
2019
Q2 		$1.14M Sell
12,340
-1,920
-13% -$182K 0.08% 123
2019
Q1 		$1.34M Sell
14,260
-2,800
-16% -$245K 0.1% 124
2018
Q4 		$1.09M Sell
17,060
-53,555
-76% -$3.95M 0.09% 122
2018
Q3 		$6.32M Buy
70,615
+6,700
+10% +$592K 0.46% 65
2018
Q2 		$5.08M Buy
63,915
+8,090
+14% +$672K 0.39% 73
2018
Q1 		$4.98M Sell
55,825
-7,550
-12% -$725K 0.38% 77
2017
Q4 		$6.61M Buy
63,375
+1,107
+2% +$125K 0.49% 51
2017
Q3 		$9.08M Sell
62,268
-2,050
-3% -$279K 0.7% 41
2017
Q2 		$8.35M Buy
64,318
+2,000
+3% +$245K 0.65% 44
2017
Q1 		$7.75M Buy
62,318
+900
+1% +$108K 0.63% 45
2016
Q4 		$7.11M Sell
61,418
-647
-1% -$72.1K 0.61% 46
2016
Q3 		$6.49M Buy
62,065
+58
+0.1% +$6.28K 0.55% 46
2016
Q2 		$6.12M Buy
62,007
+11,800
+24% +$1.22M 0.5% 54
2016
Q1 		$5.03M Buy
50,207
+800
+2% +$82.4K 0.43% 67
2015
Q4 		$5.92M Buy
49,407
+3,000
+6% +$347K 0.52% 49
2015
Q3 		$5.02M Sell
46,407
-170
-0.4% -$21.1K 0.46% 54
2015
Q2 		$5.39M Hold
46,577
– – 0.44% 56
2015
Q1 		$5.37M Buy
+46,577
New +$5.57M 0.42% 54

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Cullinan Associates's CELG Position: Q4 2019 in Review

Cullinan Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 12,340 shares — an estimated $1.23M sold.

Cullinan Associates first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $9.08M in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cullinan Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cullinan Associates sold 12,340 Celgene Corp shares in Q4 2019, an estimated $1.23M.
  • Cullinan Associates first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
  • Cullinan Associates's Celgene Corp position peaked at $9.08M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cullinan Associates's 13F filing for Q4 2019, filed 15 Jan 2020.